1
|
Tiezza MD, Ribaudo G, Orian L. Organodiselenides: Organic Catalysis and Drug Design Learning from Glutathione Peroxidase. CURR ORG CHEM 2019. [DOI: 10.2174/1385272822666180803123137] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Organodiselenides are an important class of compounds characterized by the
presence of two adjacent covalently bonded selenium nuclei. Among them,
diaryldiselenides and their parent compound diphenyl diselenide attract continuing interest
in chemistry as well as in close disciplines like medicinal chemistry, pharmacology and
biochemistry. A search in SCOPUS database has revealed that in the last three years 105
papers have been published on the archetypal diphenyl diselenide and its use in organic
catalysis and drug tests. The reactivity of the Se-Se bond and the redox properties of selenium
make diselenides efficient catalysts for numerous organic reactions, such as Bayer-
Villiger oxidations of aldehydes/ketones, epoxidations of alkenes, oxidations of alcohols
and nitrogen containing compounds. In addition, organodiselenides might find application
as mimics of glutathione peroxidase (GPx), a family of enzymes, which, besides performing other functions,
regulate the peroxide tone in the cells and control the oxidative stress level. In this review, the essential synthetic
and reactivity aspects of organoselenides are collected and rationalized using the results of accurate
computational studies, which have been carried out mainly in the last two decades. The results obtained in
silico provide a clear explanation of the anti-oxidant activity of organodiselenides and more in general of their
ability to reduce hydroperoxides. At the same time, they are useful to gain insight into some aspects of the enzymatic
activity of the GPx, inspiring novel elements for rational catalyst and drug design.
Collapse
Affiliation(s)
- Marco Dalla Tiezza
- Dipartimento di Scienze Chimiche, Universita degli Studi di, Via Marzolo 1, 35131 Padova, Italy
| | - Giovanni Ribaudo
- Dipartimento di Scienze del Farmaco, Universita degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy
| | - Laura Orian
- Dipartimento di Scienze Chimiche, Universita degli Studi di, Via Marzolo 1, 35131 Padova, Italy
| |
Collapse
|
2
|
Xie Y, Tan Y, Zheng Y, Du X, Liu Q. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. J Biol Inorg Chem 2017; 22:851-865. [PMID: 28502066 DOI: 10.1007/s00775-017-1463-2] [Citation(s) in RCA: 68] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2017] [Accepted: 04/26/2017] [Indexed: 01/13/2023]
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease which is clinically characterized by memory loss and cognitive decline caused by protein misfolding and aggregation. Imbalance between free radicals and the antioxidant system is a prominent and early feature in the neuropathology of AD. Selenium (Se), a vital trace element with excellent antioxidant potential, is preferentially retained in the brain in Se-limited conditions and has been reported to provide neuroprotection through resisting oxidative damage. In this paper, we studied for the first time the potential of Ebselen, a lipid-soluble selenium compound with GPx-like activity, in the treatment of cognitive dysfunction and neuropathology of triple-transgenic AD (3 × Tg-AD) mice, AD model cell, and primary culture. We demonstrated that Ebselen inhibited oxidative stress in both AD model cells and mouse brains with increasing GPx and SOD activities and meanwhile reduced p38 mitogen-activated protein kinases activities. By decreasing the expression of amyloid precursor protein and β-secretase, Ebselen reduced the levels of Aβ in AD neurons and mouse brains, especially the most toxic oligomeric form. Besides, mislocation of phosphorylated tau in neurons and phosphorylation levels of tau protein at Thr231, Ser396, and Ser404 residues were also inhibited by Ebselen, probably by its regulatory roles in glycogen synthase kinase 3β and protein phosphatase 2A activity. In addition, Ebselen mitigated the decrease of synaptic proteins including synaptophysin and postsynaptic density protein 95 in AD model cells and neurons. Consequently, the spatial learning and memory of 3 × Tg-AD mice were significantly improved upon Ebselen treatment. This study provides a potential novel therapeutic approach for the prevention of AD.
Collapse
Affiliation(s)
- Yongli Xie
- College of Life Sciences and Oceanography, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen, 518060, China
| | - Yibin Tan
- College of Life Sciences and Oceanography, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen, 518060, China
| | - Youbiao Zheng
- Department of Marine Biology, Shenzhen Key Laboratory of Marine Biotechnology and Ecology, Shenzhen University, Shenzhen, 518060, China
| | - Xiubo Du
- College of Life Sciences and Oceanography, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen, 518060, China.
| | - Qiong Liu
- Department of Marine Biology, Shenzhen Key Laboratory of Marine Biotechnology and Ecology, Shenzhen University, Shenzhen, 518060, China.
| |
Collapse
|
3
|
Wu WY, Dai YC, Li NG, Dong ZX, Gu T, Shi ZH, Xue X, Tang YP, Duan JA. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2017; 32:572-587. [PMID: 28133981 PMCID: PMC6009885 DOI: 10.1080/14756366.2016.1210139] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder, which is complex and progressive; it has not only threatened the health of elderly people, but also burdened the whole social medical and health system. The available therapy for AD is limited and the efficacy remains unsatisfactory. In view of the prevalence and expected increase in the incidence of AD, the design and development of efficacious and safe anti-AD agents has become a hotspot in the field of pharmaceutical research. Due to the multifactorial etiology of AD, the multitarget-directed ligands (MTDLs) approach is promising in search for new drugs for AD. Tacrine, which is the first acetylcholinesterase (AChE) inhibitor, has been selected as the ideal active fragment because of its simple structure, clear activity, and its superiority in the structural modification, thus it could be introduced into the overall molecular skeletons of the multi-target-directed anti-AD agents. In this review, we have summarized the recent advances (2012 to the present) in the chemical modification of tacrine, which could provide the reference for the further study of novel multi-target-directed tacrine derivatives to treat AD.
Collapse
Affiliation(s)
- Wen-Yu Wu
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Yu-Chen Dai
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Nian-Guang Li
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Ze-Xi Dong
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Ting Gu
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Zhi-Hao Shi
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,c Department of Organic Chemistry , China Pharmaceutical University , Nanjing , Jiangsu , China
| | - Xin Xue
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Yu-Ping Tang
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| | - Jin-Ao Duan
- a Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China.,b Department of Medicinal Chemistry , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China
| |
Collapse
|
4
|
Mao F, Chen J, Zhou Q, Luo Z, Huang L, Li X. Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. Bioorg Med Chem Lett 2013; 23:6737-42. [DOI: 10.1016/j.bmcl.2013.10.034] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2013] [Revised: 10/05/2013] [Accepted: 10/18/2013] [Indexed: 01/14/2023]
|
5
|
Unsal C, Oran M, Albayrak Y, Aktas C, Erboga M, Topcu B, Uygur R, Tulubas F, Yanartas O, Ates O, Ozen OA. Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats. Toxicol Ind Health 2013; 32:730-40. [PMID: 24231787 DOI: 10.1177/0748233713509429] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The goal of this study was to examine the neuroprotective effect of ebselen against intracerebroventricular streptozotocin (ICV-STZ)-induced oxidative stress and neuronal apoptosis in rat brain. A total of 30 adult male Sprague-Dawley rats were randomly divided into 3 groups of 10 animals each: control, ICV-STZ, and ICV-STZ treated with ebselen. The ICV-STZ group rats were injected bilaterally with ICV-STZ (3 mg/kg) on days 1 and 3, and ebselen (10 mg/kg/day) was administered for 14 days starting from 1st day of ICV-STZ injection to day 14. Rats were killed at the end of the study and brain tissues were removed for biochemical and histopathological investigation. Our results demonstrated, for the first time, the neuroprotective effect of ebselen on Alzheimer's disease (AD) model in rats. Our present study, in ICV-STZ group, showed significant increase in tissue malondialdehyde levels and significant decrease in enzymatic antioxidants superoxide dismutase and glutathione peroxidase in the frontal cortex tissue. The histopathological studies in the brain of rats also supported that ebselen markedly reduced the ICV-STZ-induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue. The number of apoptotic neurons was increased in frontal cortex tissue after ICV-STZ administration. Treatment of ebselen markedly reduced the number of degenerating apoptotic neurons. The study demonstrates the effectiveness of ebselen, as a powerful antioxidant, in preventing the oxidative damage and morphological changes caused by ICV-STZ in rats. Thus, ebselen may have a therapeutic value for the treatment of AD.
Collapse
Affiliation(s)
- Cuneyt Unsal
- Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Mustafa Oran
- Department of Internal Medicine, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Yakup Albayrak
- Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Cevat Aktas
- Department of Histology and Embryology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Mustafa Erboga
- Department of Histology and Embryology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Birol Topcu
- Department of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Ramazan Uygur
- Department of Anatomy, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Feti Tulubas
- Department of Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Omer Yanartas
- Department of Psychiatry, The Ministry of Health of Turkey, Marmara University Hospital Pendik Training and Research Hospital, Istanbul, Turkey
| | - Ozkan Ates
- Department of Neurosurgery, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| | - Oguz Aslan Ozen
- Department of Anatomy, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
| |
Collapse
|
6
|
Santofimia-Castaño P, Salido GM, González A. Ebselen alters mitochondrial physiology and reduces viability of rat hippocampal astrocytes. DNA Cell Biol 2013; 32:147-55. [PMID: 23496767 DOI: 10.1089/dna.2012.1939] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The seleno-organic compound and radical scavenger ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) have been extensively employed as an anti-inflammatory and neuroprotective compound. However, its glutathione peroxidase activity at the expense of cellular thiols groups could underlie certain deleterious actions of the compound on cell physiology. In this study, we have analyzed the effect of ebselen on rat hippocampal astrocytes in culture. Cellular viability, the intracellular free-Ca(2+) concentration ([Ca(2+)]c), the mitochondrial free-Ca(2+) concentration ([Ca(2+)]m), and mitochondrial membrane potential (ψm) were analyzed. The caspase-3 activity was also assayed. Our results show that cell viability was reduced by treatment of cells with ebselen, depending on the concentration employed. In the presence of ebselen, we observed an initial transient increase in [Ca(2+)]c that was then followed by a progressive increase to an elevated plateau. We also observed a transient increase in [Ca(2+)]m in the presence of ebselen that returned toward a value over the prestimulation level. The compound induced depolarization of ψm and altered the permeability of the mitochondrial membrane. Additionally, a disruption of the mitochondrial network was observed. Finally, we did not detect changes in caspase-3 activation in response to ebselen treatment. Collectively, these data support the likelihood of ebselen, depending on the concentration employed, reduces viability of rat hippocampal astrocytes via its action on the mitochondrial activity. These may be early effects that do not involve caspase-3 activation. We conclude that, depending on the concentration used, ebselen might exert deleterious actions on astrocyte physiology that could compromise cell function.
Collapse
|
7
|
Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake. Neurochem Int 2012; 61:334-40. [DOI: 10.1016/j.neuint.2012.05.016] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2011] [Revised: 05/11/2012] [Accepted: 05/13/2012] [Indexed: 12/14/2022]
|
8
|
Dalla Corte CL, Bastos LL, Dobrachinski F, Rocha JB, Soares FA. The combination of organoselenium compounds and guanosine prevents glutamate-induced oxidative stress in different regions of rat brains. Brain Res 2012; 1430:101-11. [DOI: 10.1016/j.brainres.2011.10.049] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Revised: 10/07/2011] [Accepted: 10/28/2011] [Indexed: 10/15/2022]
|
9
|
Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol 2011; 85:1313-59. [DOI: 10.1007/s00204-011-0720-3] [Citation(s) in RCA: 330] [Impact Index Per Article: 25.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2011] [Accepted: 05/18/2011] [Indexed: 02/07/2023]
|
10
|
Yin Z, Lee E, Ni M, Jiang H, Milatovic D, Rongzhu L, Farina M, Rocha JBT, Aschner M. Methylmercury-induced alterations in astrocyte functions are attenuated by ebselen. Neurotoxicology 2011; 32:291-9. [PMID: 21300091 PMCID: PMC3079013 DOI: 10.1016/j.neuro.2011.01.004] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2010] [Revised: 12/21/2010] [Accepted: 01/08/2011] [Indexed: 12/26/2022]
Abstract
Methylmercury (MeHg) preferentially accumulates in glia of the central nervous system (CNS), but its toxic mechanisms have yet to be fully recognized. In the present study, we tested the hypothesis that MeHg induces neurotoxicity via oxidative stress mechanisms, and that these effects are attenuated by the antioxidant, ebselen. Rat neonatal primary cortical astrocytes were pretreated with or without 10 μM ebselen for 2h followed by MeHg (0, 1, 5, and 10 μM) treatments. MeHg-induced changes in astrocytic [(3)H]-glutamine uptake were assessed along with changes in mitochondrial membrane potential (ΔΨ(m)), using the potentiometric dye tetramethylrhodamine ethyl ester (TMRE). Western blot analysis was used to detect MeHg-induced ERK (extracellular-signal related kinase) phosphorylation and caspase-3 activation. MeHg treatment significantly decreased (p<0.05) astrocytic [(3)H]-glutamine uptake at all time points and concentrations. Ebselen fully reversed MeHg's (1 μM) effect on [(3)H]-glutamine uptake at 1 min. At higher MeHg concentrations, ebselen partially reversed the MeHg-induced astrocytic inhibition of [(3)H]-glutamine uptake [at 1 min (5 and 10 μM) (p<0.05); 5 min (1, 5 and 10 μM) (p<0.05)]. MeHg treatment (1h) significantly (p<0.05) dissipated the ΔΨ(m) in astrocytes as evidenced by a decrease in mitochondrial TMRE fluorescence. Ebselen fully reversed the effect of 1 μM MeHg treatment for 1h on astrocytic ΔΨ(m) and partially reversed the effect of 5 and 10 μM MeHg treatments for 1h on ΔΨ(m). In addition, ebselen inhibited MeHg-induced phosphorylation of ERK (p<0.05) and blocked MeHg-induced activation of caspase-3 (p<0.05-0.01). These results are consistent with the hypothesis that MeHg exerts its toxic effects via oxidative stress and that the phosphorylation of ERK and the dissipation of the astrocytic mitochondrial membrane potential are involved in MeHg toxicity. In addition, the protective effects elicited by ebselen reinforce the idea that organic selenocompounds represent promising strategies to counteract MeHg-induced neurotoxicity.
Collapse
MESH Headings
- Analysis of Variance
- Animals
- Animals, Newborn
- Antioxidants/pharmacology
- Astrocytes/drug effects
- Astrocytes/metabolism
- Astrocytes/pathology
- Azoles/pharmacology
- Blotting, Western
- Caspase 3/metabolism
- Cells, Cultured
- Cytoprotection
- Dose-Response Relationship, Drug
- Environmental Pollutants/toxicity
- Extracellular Signal-Regulated MAP Kinases/metabolism
- Glutamine/metabolism
- Isoindoles
- Membrane Potential, Mitochondrial/drug effects
- Mercury Poisoning, Nervous System/etiology
- Mercury Poisoning, Nervous System/metabolism
- Mercury Poisoning, Nervous System/pathology
- Methylmercury Compounds/toxicity
- Microscopy, Fluorescence
- Mitochondria/drug effects
- Mitochondria/metabolism
- Neuroprotective Agents/pharmacology
- Organoselenium Compounds/pharmacology
- Oxidative Stress/drug effects
- Phosphorylation
- Rats
- Rats, Sprague-Dawley
- Time Factors
Collapse
Affiliation(s)
- Zhaobao Yin
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Eunsook Lee
- Department of Physiology, Meharry Medical College, Nashville, Tennessee
| | - Mingwei Ni
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Haiyan Jiang
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Dejan Milatovic
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Lu Rongzhu
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Marcelo Farina
- Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil
| | - Joao B. T. Rocha
- Departamento de Bioquímica, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil
| | - Michael Aschner
- Departments of Pediatrics and Pharmacology, the Kennedy Center for Research on Human Development, Vanderbilt University Medical Center, Nashville, Tennessee
| |
Collapse
|
11
|
|
12
|
Posser T, Franco JL, dos Santos DA, Rigon AP, Farina M, Dafré AL, Teixeira Rocha JB, Leal RB. Diphenyl diselenide confers neuroprotection against hydrogen peroxide toxicity in hippocampal slices. Brain Res 2008; 1199:138-47. [DOI: 10.1016/j.brainres.2008.01.004] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2007] [Revised: 12/28/2007] [Accepted: 01/03/2008] [Indexed: 01/05/2023]
|
13
|
Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats. Brain Res 2007; 1181:83-92. [DOI: 10.1016/j.brainres.2007.08.072] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2007] [Revised: 08/17/2007] [Accepted: 08/25/2007] [Indexed: 12/20/2022]
|
14
|
Rosa R, Roesler R, Braga A, Saffi J, Henriques J. Pharmacology and toxicology of diphenyl diselenide in several biological models. Braz J Med Biol Res 2007; 40:1287-304. [DOI: 10.1590/s0100-879x2006005000171] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Affiliation(s)
- R.M. Rosa
- Universidade Federal do Rio Grande do Sul
| | - R. Roesler
- Universidade Federal do Rio Grande do Sul, Brasil
| | - A.L. Braga
- Universidade Federal de Santa Maria, Brasil
| | - J. Saffi
- Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil, Brasil
| | - J.A.P. Henriques
- Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil, Brasil
| |
Collapse
|
15
|
Kade IJ, Paixão MW, Rodrigues OED, Barbosa NBV, Braga AL, Avila DS, Nogueira CW, Rocha JBT. Comparative Studies on Dicholesteroyl Diselenide and Diphenyl Diselenide as Antioxidant Agents and their Effect on the Activities of Na+/K+ ATPase and δ-Aminolevulinic acid Dehydratase in the Rat Brain. Neurochem Res 2007; 33:167-78. [PMID: 17710541 DOI: 10.1007/s11064-007-9432-8] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2007] [Accepted: 06/29/2007] [Indexed: 10/22/2022]
Abstract
The present study sought to evaluate the effect of a newly synthesized selenium compound, dicholesteroyl diselenide (DCDS) and diphenyl diselenide (DPDS) on the activities of delta-aminolevulinate dehydratase and Na+/K+-ATPase in the rat brain. The glutathione peroxidase mimetic activity of the two compounds as well as their ability to oxidize mono- and di- thiols were also evaluated. The antioxidant effects were tested by measuring the ability of the compounds to inhibit the formation of thiobarbituric acid reactive species and also their ability to inhibit the formation of protein carbonyls. The results show that DPDS exhibited a higher glutathione peroxidase mimetic activity as well as increased ability to oxidize di-thiols than DCDS. In addition, while DPDS inhibited the formation of thiobarbituric acid reactive species and protein carbonyls, DCDS exhibited a prooxidant effect in all the concentration range (20-167 microM) tested. Also the activities of cerebral delta-aminolevulinate dehydratase and Na+/K+ ATPase were significantly inhibited by DPDS but not by DCDS. In addition, the present results suggested that the inhibition of Na+/K+ ATPase by organodiselenides, possibly involves the modification of the thiol group at the ATP binding site of the enzyme. In conclusion, the results of the present investigation indicated that the non-selenium moiety of the organochalcogens can have a profound effect on their antioxidant activity and also in their reactivity towards SH groups from low-molecular weight molecules and from brain proteins.
Collapse
Affiliation(s)
- Ige J Kade
- Departamento de Química, Centro Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Moretto MB, Thomazi AP, Godinho G, Roessler TM, Nogueira CW, Souza DO, Wofchuk S, Rocha JBT. Ebselen and diorganylchalcogenides decrease in vitro glutamate uptake by RAT brain slices: Prevention by DTT and GSH. Toxicol In Vitro 2007; 21:639-45. [PMID: 17321101 DOI: 10.1016/j.tiv.2006.12.014] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2006] [Revised: 12/01/2006] [Accepted: 12/26/2006] [Indexed: 10/23/2022]
Abstract
The purpose of this study was to investigate the possible involvement of the glutamatergic system in the neurotoxicity of diorganylchalcogenides or organochalcogenides from slices of cerebral cortex in different ages of development: 12- and 60-day-old rats. Glutamate uptake was evaluated in cortical slices of 12 and 60 days old rats. Cortex slices were incubated with three different organochalcogenides with or without reduced glutathione or dithiothreitol. At 100 microM, ebselen, diphenyl diselenide (PhSe)2 and diphenyl ditelluride (PhTe)2 in vitro inhibited the [3H]glutamate uptake in both age. Both 60-day-old rats and for 12-day-old rats, GSH and DTT prevented the (PhTe)2-induced inhibition of glutamate uptake but did not protect the inhibition caused by ebselen and (PhSe)2. These findings suggest that the neurotoxicity of organochalcogenides could be related to their effects on brain glutamate uptake, conceivably involving a redox modulation of reactive amino acids from the glutamate transporter proteins.
Collapse
Affiliation(s)
- M B Moretto
- Departamento de Análises Clínicas e Toxicológicas, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Xu JH, Hu HT, Liu Y, Qian YH, Liu ZH, Tan QR, Zhang ZJ. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons. Neurosci Lett 2006; 399:210-4. [PMID: 16513270 DOI: 10.1016/j.neulet.2006.02.024] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2005] [Revised: 02/01/2006] [Accepted: 02/02/2006] [Indexed: 11/16/2022]
Abstract
There is little information available on the mechanisms underlying the neuroprotective actions of the organoselenium compound ebselen. In this study, we sought to determine the relationship between alterations in the expression of Bcl-2 and Bax proteins and intracellular levels of calcium and the protective effects of ebselen with a concentration range of 0.01-20 microM against glutamate toxicity in cultured mouse cortical neurons. Pretreatment with ebselen at moderate doses (4-12 microM), but not at lower or higher doses, significantly improved glutamate-induced suppression of cell viability. Pretreatment with ebselen (8 microM) also prevented apoptotic alterations, completely reversed the suppression of Bcl-2 expression, and significantly inhibited Bax overexpression, but did not alter elevated intracellular concentrations of calcium induced by glutamate. Pre-, co-, and post-treatment with ebselen (8 microM) had similar potency in improving the decreased viability of glutamate-exposed cells. These results indicate that the neuroprotective effects of ebselen at low doses are associated with the regulation of Bcl-2 and Bax proteins but appear to be independent of glutamate-mediated elevation of intracellular calcium, suggesting that different mechanisms are involved in the actions of low and high dose regimens. Ebselen may be an effective agent used for early treatment of acute brain injuries.
Collapse
Affiliation(s)
- Jie-Hua Xu
- Department of Human Anatomy and Histoembryology, College of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China
| | | | | | | | | | | | | |
Collapse
|